journal article·2021-04-04Open access

The Drug-Loaded Electrospun Poly(ε-Caprolactone) Mats for Therapeutic Application

Alena Opálková Šišková, Mária Bučková, Zuzana Kroneková, Angela Kleinová, Štefan Nagy, Joanna Rydz, Andrej Opálek, Monika Sláviková, Anita Eckstein Andicsová

Nanomaterials· Volume 11· Issue 4

Abstract

Diclofenac sodium salt (DSS)-loaded electrospun nanofiber mats on the base of poly(ε-caprolactone) (PCL) were investigated as biocompatible nanofibrous mats for medical applications with the ability to inhibit bacterial infections. The paper presents the characteristics of fibrous mats made by electrospinning and determines the effect of medicament on the fiber morphology, chemical, mechanical and thermal properties, as well as wettability. PCL and DSS-loaded PCL nanofibrous mats were characterized using scanning electron microscopy, transmission electron microscopy, attenuated total reflectance-Fourier transform infrared spectrometry, dynamic mechanical analysis, and contact angle measurements. Electron paramagnetic resonance measurements confirmed the lifetime of DSS before and after application of high voltage during the electrospinning process. In vitro biocompatibility was studied, and it was proved to be of good viability with ~92% of the diploid human cells culture line composed of lung fibroblast (MRC 5) after 48 h of incubation. Moreover, the significant activity of DSS-loaded nanofibers against cancer cells, Ca Ski and HeLa, was established as well. It was shown that 12.5% (m/V) is the minimal concentration for antibacterial activity when more than 99% of Escherichia coli (Gram-negative) and 99% of Staphylococcus aureus (Gram-positive) have been exterminated.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Advanced Sensor and Energy Harvesting Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Polymer Institute of Slovak Academy of Sciences, Dúbravská Cesta 9, 845 41 Bratislava, Slovakia

Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 51 Bratislava, Slovakia

Institute of Materials and Machine Mechanics, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 13 Bratislava, Slovakia

Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowska 34, 41-800 Zabrze, Poland

Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia

Funding

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV · Agentúra na Podporu Výskumu a Vývoja · SAS-MOST · SAS-PAS · Research & Innovation Operational Programme funded by the ERDF

References (82)

Show source-provided references
1. Current development of biodegradable polymeric materials for biomedical applications10.2147/DDDT.S165440 ↗
2. Mochane, M.J., Motsoeneng, T.S., Sadiku, E.R., Mokhena, T.C., and Sefadi, J.S. (2019). Morphology and properties of electrospun PCL and its composites for medical applications: A mini review. Appl. Sci., 9.10.3390/app9112205 ↗
3. Physical and antibacterial properties of peppermint essential oil loaded poly(ε-caprolactone) (pcl) electrospun fiber mates for wound healing10.3389/fbioe.2019.00346 ↗
4. Yung, S.M., Min, S.K., Lee, H.C., Kwon, Y.S., Jung, M.H., and Shin, H.S. (2016). Spirulina-pcl nanofiber wound dressing to improve cutaneous wound healing by enhancing antioxidative mechanism. J. Nanomater., 6135727.10.1155/2016/6135727 ↗
5. PCL and PCL-Based Materials in Biomedical Applications10.1080/09205063.2017.1394711 ↗
6. The return of a forgotten polymer—polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
7. Souza, M.A., Sakamoto, K.Y., and Mattoso, L.H.C. (2014). Release of the diclofenac sodium by nanofibers of poly(hydroxybutyrate-co-3-hydroxyvalerate) obtained from electrospinning and solution blow spinning. J. Nanomater., 129035.10.1155/2014/129035 ↗
8. Drug delivery from polymer-based nanopharmaceuticals—An experimental study complemented by simulations of selected diffusion processes10.3389/fbioe.2019.00037 ↗
9. Stimuli-responsive polymeric micelles for drug delivery and anticancer therapy10.2147/IJN.S158696 ↗
10. Natural polymeric scaffolds in bone regeneration10.3389/fbioe.2020.00474 ↗
11. Nanonet-nano fiber electrospun mesh of PCL–chitosan for controlled and extended release of diclofenac sodium10.1039/D0NR05968D ↗
12. Polymeric engineering of nanoparticles for highly efficent multifunctional drug delivery systems10.1038/s41598-019-39107-3 ↗
13. Calzoni, E., Cesaretti, A., Polchi, A., di Michele, A., Tancini, B., and Emiliani, C. (2019). Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J. Funct. Biomater., 10.10.3390/jfb10010004 ↗
14. Characterization, drug loading and antibacterial activity of nanohydroxyapatite/polycaprolactone (nHA/PCL) electrospun membrane10.1007/s13205-017-0889-0 ↗
15. Naproxen conjugated mPEG-PCL micelles for dual triggered drug delivery10.1016/j.msec.2015.12.067 ↗
16. Polymeric micelles for anticancer drug delivery10.4155/tde-2020-0008 ↗
17. Rios-Doria, J., Carie, A., Costich, T., Burke, B., Skaff, H., Panicucci, R., and Sill, K. (2012). A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugs. J. Drug. Deliv., 951741.10.1155/2012/951741 ↗
18. Mucoadhesive electrospun nanofibers for drug delivery systems: Applications of polymers and the parameter’ roles10.2147/IJN.S193328 ↗
19. Fast-dissolving antibacterial nanofibers of cyclodextrin/antibiotic inclusion complexes for oral drug delivery10.1016/j.jcis.2020.11.072 ↗
20. Nanofibers for drug delivery—incorporation and release of model molecules, influence of molecular weight and polymer structure10.3762/bjnano.6.198 ↗
21. Alven, S., Nqoro, X., Buyana, B., and Aderibigbe, B.A. (2020). Polymer-drug conjugate, a potential therapeutic to combat breast and lung cancer. Pharmaceutics, 12.10.3390/pharmaceutics12050406 ↗
22. Polymeric conjugates for drug delivery10.1021/cm2031569 ↗
23. Kostková, H., Schindler, L., Kotrchová, L., Kovář, M., Šírová, M., Kostka, L., and Etrych, T. (2017). Star polymer-drug conjugates with pH-controlled drug release and carrier degradation. J. Nanomater., 8675435.10.1155/2017/8675435 ↗
24. Effects of some electrospinning parameters on morphology of natural silk-based nanofibers10.1002/app.29808 ↗
25. Zafar, M., Najeeb, S., Khurshid, Z., Vazirzadeh, M., Zohaib, S., Najeeb, B., and Sefat, F. (2016). Potential of electrospun nanofibers for biomedical and dental applications. Materials, 9.10.3390/ma9020073 ↗
26. Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained diclofenac prodrug to treat actinic keratosis10.1016/j.actbio.2016.11.002 ↗
27. Fabrication of electrospun poly(D,L lactide-co-glicolide) 80/20 scaffolds loaded with diclofenac sodium for tissue engineering10.1186/s40001-015-0145-1 ↗
28. Drugs loaded into electrospun polymeric nanofibers for delivery10.18433/jpps29674 ↗
29. Moving polyvinyl pyrrolidone electrospun nanofibers and bioprinted scaffolds toward multidisciplinary biomedical applications10.1016/j.eurpolymj.2020.109919 ↗
30. Bioactive polymeric scaffolds for tissue engineering
31. Hybrid polyester-hydrogel electrospun scaffold for tissue engineering applications10.3389/fbioe.2019.00231 ↗
32. Electrospun nanofibers for customized drug-delivery systems10.1016/j.jddst.2019.03.038 ↗
33. Electrospun fibre composite for controlled drug release10.1557/adv.2020.268 ↗
34. Electrospun diclofenac sodium loaded Eudragit®L 100-55 nanofibers for colon-targeted drug delivery10.1016/j.ijpharm.2011.01.058 ↗
35. Mayorek, N., Naftali-Shani, N., and Grunewald, M. (2010). Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PLoS ONE, 5.10.1371/journal.pone.0012715 ↗
36. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells10.1016/j.lungcan.2009.06.012 ↗
37. Valle, B.L., D’Souza, T., Becker, K.G., Wood, W.H., Zhang, Y., Wersto, R.P., and Morin, P.J. (2013). Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells. PLoS ONE, 8.10.1371/journal.pone.0061836 ↗
38. Advances in NSAID Development: Evolution of diclofenac products using pharmaceutical technology10.1007/s40265-015-0392-z ↗
39. Nugrahani, I., Utami, D., Permana, B., and Ibrahim, S. (2018). Development of the NSAID-L-Proline Amino Acid Zwitterionic Cocrystals. J. Appl. Pharm. Sci., 57–63.10.7324/JAPS.2018.8408 ↗
40. Bandeira, M., Borges, V., Gomes, J.P., Duarte, A., and Jordao, L. (2017). Insight on Klebsiella pneumoniae biofilms assembled on different surfaces using phenotypic and genotypic approaches. Microorganisms, 5.10.3390/microorganisms5020016 ↗
41. International Organization for Standardization (2011). Measurement of Antibacterial Activity on Plastics and Other Non-Porous Surfaces, International Organization for Standardization. ISO 22196.
42. Ezhilarasu, H., Ramalingam, R., Dhand, C., Lakshminarayanan, R., Sadiq, A., Gandhimathi, C., Ramakrishna, S., Bay, B.H., Venugopal, J.R., and Srinivasan, D.K. (2019). Biocompatible aloe vera and tetracycline hydrochloride loaded hybrid nanofibrous scaffolds for skin tissue engineering. Int. J. Mol. Sci., 20.10.3390/ijms20205174 ↗
43. Spontaneous formation of nanoparticles on electrospun nanofibres10.1038/s41467-018-07243-5 ↗
44. Effect of changing solvents on poly(ε-caprolactone) nanofibrous webs morphology
45. Electrospinning of polycaprolactone nanofibers with DMF additive: The effect of solution properties on jet perturbation and fiber morphologies10.1007/s12221-016-6045-3 ↗
46. Porous electrospun polycaprolactone (PCL) fibers by phase separation10.1016/j.eurpolymj.2015.01.028 ↗
47. Electrospun polycaprolactone scaffolds using an ionic liquid as alternative solvent: Morphometric, mechanical and biological properties
48. Acetone, a sustainable solvent for electrospinning poly(ε-caprolactone) fibers: Effect of varying parameters and solution concentration on fibre diameter10.1007/s10924-012-0436-3 ↗
49. Effect of different solvents on poly(caprolactone) (PCL) electrospun nonwoven membranes10.1007/s10973-011-1640-4 ↗
50. Cheremisinoff, N. (2008). Industrial Solvents Handbook, Marcel Dekker Inc.. [2nd ed.].
51. Liverani, L., and Boccaccini, A.R. (2016). Versatile production of poly(epsilon-caprolactone) fibers by electrospinning using benign solvents. Nanomaterials, 6.10.3390/nano6040075 ↗
52. Marsella, J.A. (2013). Dimethylformamide. Kirk-Othmer Encyclopedia of Chemical Technology, Wiley. Updated by Staff.10.1002/0471238961.0409130513011819.a01.pub2 ↗
53. Tammaro, L., Russo, G., and Vittoria, V. (2009). Encapsulation of diclofenac molecules into poly(ε-caprolactone) electrospun fibers for delivery protection. J. Nanomater., 238206.10.1155/2009/238206 ↗
54. Tuning surface texture of electrospun polycaprolactone fibers: Effects of solvent systems and relative humidity
55. Electrospinning of polycaprolactone in dichloromethane/dimethylformamide solvent system
56. Abutaleb, A., Lolla, D., Aljuhani, A., Shin, H.U., Rajala, J.W., and Chase, G.G. (2017). Effect of surfactants on the morphology and properties of electrospun polyetherimide fibers. Fibers, 5.10.3390/fib5030033 ↗
57. Influence of salt addition on polymer-free electrospinning of cyclodextrin nanofibers10.1088/2632-959X/abb6c5 ↗
58. Šišková, A.O., Kozma, E., Opálek, A., Kroneková, Z., Kleinová, A., Nagy, Š., Kronek, J., Rydz, J., and Eckstein Andicsová, A. (2020). Diclofenac embedded in silk fibroin fibers as a drug delivery system. Materials, 13.10.3390/ma13163580 ↗
59. New applications of electron diffraction in the pharmaceutical industry: Polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques10.1017/S1431927601020050 ↗
60. Fini, A., Cavallari, C., and Ospitali, F. (2010). Diclofenac salts. V. Examples of polymorphism among diclofenac salts with alkyl-hydroxy amines studied by DSC and HSM. Pharmaceutics, 2.10.3390/pharmaceutics2020136 ↗
61. FTIR study of polycaprolactone chain organization at interfaces10.1016/j.jcis.2004.02.001 ↗
62. Evaluation of Prunus domestica gum as a novel tablet binder10.1590/S1984-82502011000100020 ↗
63. Study on mechanical & thermal properties of PCL blended graphene biocomposites10.1590/0104-1428.05318 ↗
64. Thermal and Thermomechanical Behaviour of polycaprolactone and starch/polycaprolactone blends for biomedical applications10.1002/mame.200500003 ↗
65. Thermal Behaviour of diclofenac sodium: Decomposition of melting characteristics10.1248/cpb.49.1245 ↗
66. Thermal decomposition of some analgesic agents10.1007/BF01980770 ↗
67. Mechanical considerations for electrospun nanofibers in tendon and ligament repair10.1002/adhm.201701277 ↗
68. Biodegradable electrospun nanofibers coated with platelet-rich plasma for cell adhesion and proliferation10.1016/j.msec.2014.03.065 ↗
69. Diclofenac release from polycaprolactone 3D matrices produced by electrospinning: Influence of fiber structure and composition of the surrounding medium10.1080/00914037.2018.1525720 ↗
70. Size dependent mechanical properties of electrospun polymer fibers from a composite structure10.1016/j.polymer.2012.08.064 ↗
71. Szewczyk, P.K., Ura, P.D., Metwally, S., Kanpczyk-Korczak, J., Gajek, M., Marzec, M.M., Bernasik, A., and Stachewicz, U. (2019). Roughness and fiber fraction dominated wetting of electrospun fiber-based porous meshes. Polymers, 11.10.3390/polym11010034 ↗
72. Fabrication of superhydrophobic polycaprolactone/beeswax electrospun membranes for high-efficiency oil/water separation10.1039/C6RA26123J ↗
73. Diclofenac-Choline Antioxidant Activity Investigated by Means of Luminol Amplified Chemiluminescence of Human Neutrophil Bursts and Electron Paramagnetic Resonance Spectroscopy
74. Leão, C., Borges, A., and Simões, M. (2020). NSAIDs as drug repurposing strategy for biofilm control. Antibiotics, 9.10.3390/antibiotics9090591 ↗
75. Non-antibiotic compounds: The activity of the NSAID diclofenac on bacteria- a review10.20546/ijcmas.2018.712.042 ↗
76. On the etiological relevance of Escherichia coli and staphylococcus aureus in superficial and deep infections—A hypothesis-forming, retrospective assessment10.1556/1886.2019.00021 ↗
77. Sarwar, M.N., Ullah, A., Haider, M.K., Hussain, N., Ullah, S., Hashimi, M., Khan, M.Q., and Kim, I.S. (2021). Evaluating antibacterial efficacy and biocompatibility of PAN nanofibers loaded with diclofenac sodium salt. Polymers, 13.10.3390/polym13040510 ↗
78. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management10.1128/CMR.00134-14 ↗
79. Escherichia coli infections10.1542/pir.36.4.167 ↗
80. Characterization of the surface biocompatibility of the electrospun PCL-collagen nanofibers using fibroblasts10.1021/bm050314k ↗
81. Use of electrospinning technique for biomedical applications10.1016/j.polymer.2008.09.014 ↗
82. PCL/PEG electrospun fibers as drug carriers for the controlled delivery of dipyridamole